InvestorWire NewsRoom

InvestorNewsBreaks

NewsBreak Category: Tiny Gems
Thursday Jul 21, 2022 - 2:16 pm

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Reminder for Upcoming Annual Shareholder Meeting

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today issued a reminder for its current shareholders regarding the upcoming annual shareholder meeting. Beginning at 9:30 a.m. ET on July 26, 2022, Mullen will conduct a required formal shareholder meeting, which will be followed by a company presentation by David Michery, CEO and chairman of Mullen Automotive. The in-person meeting will be held at…

Continue Reading

Wednesday Jul 20, 2022 - 3:02 pm

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Unlocking ‘New Frontiers of Discovery’ with Kernel Flow

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various conditions, has announced preliminary data from a feasibility study using Kernel Flow. The results indicate that ketamine-induced changes in functional connectivity last for several days after administration of the substance. “Kernel Flow is the first easy-to-use, wearable device that collects and measures real-time brain activity before, during…

Continue Reading

Wednesday Jul 20, 2022 - 2:42 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Expanding Patient Eligibility in Potentially Pivotal Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently announced that its global clinical trial for a potentially pivotal brain cancer treatment will expand patient eligibility following an amendment to its protocol for the study. “CNS has been enrolling patients in its phase II clinical trial for novel drug candidate Berubicin, which has shown promise in fighting the aggressive brain cancer glioblastoma (‘GBM’),” explains a recent article. “The trial…

Continue Reading

Tuesday Jul 19, 2022 - 1:16 pm

InvestorNewsBreaks – Why Freight Technologies Inc. (NASDAQ: FRGT) Is ‘One to Watch’

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process. The company is on a mission to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity. A recent article reads: “Fr8Tech leverages artificial intelligence to provide cloud-based platforms aimed at automating the over-the-road (‘OTR’) transportation process, effectively reducing…

Continue Reading

Monday Jul 18, 2022 - 1:29 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Poised for First-Mover Advantage

Flora Growth Corp. (NASDAQ: FLGC) is aggressively pushing its brand and advancing the conversation around cannabis. “In addition, with its able management, Flora is recognizing and capitalizing on opportunities that others are yet to identify, placing it in a unique position that not only gives it a first-mover advantage but also presents a unique opportunity for growth,” a recent article that discusses a research report…

Continue Reading

Monday Jul 18, 2022 - 12:51 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Partners to Propel New, Exciting Growth Opportunities

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently entered into agreements with beverage developer BevNology. “The BevNology collaboration not only includes a commercial license agreement for products with active ingredients derived from hemp under BevNology’s brand but also a manufacturing operating agreement utilizing BevNology’s new, custom-built state-of-the-art processing facility outside Atlanta…. The manufacturing agreement will help Lexaria broaden its production…

Continue Reading

Monday Jul 18, 2022 - 10:05 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Michael Woudenberg as Chief Operating Officer

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced its appointment of Michael Woudenberg as chief operating officer of the company, overseeing all day-to-day operations. Woudenberg previously served as senior vice president of chemistry, manufacturing and controls. For the past several years, he has been an integral part of InMed’s executive team, supporting multiple functions within…

Continue Reading

Friday Jul 15, 2022 - 12:38 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Working to Make Lidar a Standard Feature of Today’s Cars, Key Component of Future Autonomous Vehicles

Cepton (NASDAQ: CPTN) is an innovator and leader specializing in high-performance Micro Motion Technology (“MMT(R)”) lidar solutions that enable reliable, scalable, long-range, high-resolution 3D perception for smart applications. The company was recently added to the Russell 3000(R) Index, effective June 27, 2022, following its rapid growth over the last year. According to co-founder and CEO Dr. Jun Pei, the inclusion in the Russell 3000(R) Index…

Continue Reading

Thursday Jul 14, 2022 - 2:00 pm

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Equipping Physicians, Individuals with Comprehensive Immune System Views

Aditxt (NASDAQ: ADTX) provides the AditxtScore(TM), a proprietary immune mapping technology designed to provide a personalized profile of the immune system. “Licensed from Stanford University, AditxtScore(TM) for COVID-19 is Aditxt’s first commercial product. It enables patients to know the level of protection that an immune response to the SARS-CoV-2 virus or vaccination confers them…The results may also influence the vaccine-hesitant populace to take the vaccine,…

Continue Reading

Wednesday Jul 13, 2022 - 3:12 pm

InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Expands IP Estate with Receipt of Third US Patent for CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) is a company developing next-generation targeted therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (“CycloSam(R)”), for the treatment of cancer and related diseases. The company today announced that the United States Patent & Trademark Office has granted a key patent protecting how CycloSam(R) is formulated and prepared, namely by using a nonradioactive kit that can be delivered and stored local to the administration site and…

Continue Reading

Wednesday Jul 13, 2022 - 12:39 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Nearing Start Date for Its Human Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the pending start of its upcoming human nicotine study NIC-H22-1. Through the study, Lexaria expects to evidence that processing purified nicotine with its patented drug delivery technology, DehydraTECH(TM), leads to enhanced oral-tissue absorption and reduced negative experiences. NIC-H22-1, a minimum 36-person human pharmacokinetic (“PK”) randomized, double blinded, cross-over study, will compare…

Continue Reading

Tuesday Jul 12, 2022 - 1:04 pm

InvestorNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) CYB003 Phase 1/2a Clinical Trial Through Clinilabs Begins Enrollment

Clinilabs Drug Development Corporation, a global, full-service contract research organization with deep expertise in central nervous system drug development, today announced commencement of enrollment in a phase 1/2a clinical trial of CYB003. Being developed by Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” CYB003 is the first novel psilocybin analog to be evaluated in phase 1/2a…

Continue Reading

Tuesday Jul 12, 2022 - 10:00 am

InvestorNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Milestone Agreement with DPL Featured in NGT News Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, recently signed a binding agreement with DelPack Logistics LLC (“DPL”), an Amazon delivery service partner, for DPL to purchase up to 600 Mullen Class 2 EV cargo vans over a period of 18 months. The vans will be fully homologated for the United States, of which the first 300 can be delivered by Nov. 30,…

Continue Reading

Tuesday Jul 12, 2022 - 9:48 am

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Upgrades EDI to Include Location Sharing, Shipment Status Improvements

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process and providing a platform for B2B cross-border shipping in the NAFTA region, announced that it has upgraded its electronic data interchange (“EDI”). The upgraded EDI now features the ability to enable location sharing and shipment status changes. “To help increase Fr8App large shippers’ efficiency and the stickiness of…

Continue Reading

Monday Jul 11, 2022 - 2:05 pm

InvestorNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Secures New Contract from Large Real Estate Investment Trust (REIT)

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, announced its receipt of another new contract for autonomous security robot (ASR) services. The announcement reads, “One of the largest U.S. real estate investment trusts (REIT) signed an agreement for Knightscope’s K5 ASR to patrol one of its open-air, mixed-use shopping centers in southern Florida. As of 2022, the…

Continue Reading

Monday Jul 11, 2022 - 10:30 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Enters Agreement Putting Cargo Van Program ‘Front and Center for Last Mile Delivery Opportunities’

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its entry into a binding agreement with DelPack Logistics LLC (“DPL”), an Amazon Delivery Service Partner, for DPL to purchase up to 600 Mullen Class 2 EV cargo vans over the next 18 months. The vans will be fully homologated for the United States and equipped with all airbags as required by U.S.…

Continue Reading

Monday Jul 11, 2022 - 10:01 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Expected to Accelerate Clinical Development Path of CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that, through its wholly-owned subsidiary Cybin IRL Limited, it has completed the acquisition of a phase 1 N,N-dimethyltryptamine (“DMT”) study from Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1). The DMT study, which is the largest to date, is expected to accelerate the clinical development path of…

Continue Reading

Friday Jul 08, 2022 - 2:45 pm

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Achieves 221% YoY Quarterly Revenue Growth

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, recently reported financial results for its second fiscal quarter, with quarterly revenues rising by 221% year-over-year to $8,482,743. “Meanwhile, Q2 net income rose to $586,984, a significant increase relative to the $127,986 recorded in the equivalent period a year ago. Golden Matrix Group attributed part of the significant increase…

Continue Reading

Friday Jul 08, 2022 - 12:40 pm

InvestorNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Secures New Contract with Storage Facility in Napa Valley

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, announced its entry into a new agreement with a storage facility in Napa, California. The announcement reads, “The use of storage facilities has increased 65% over the past 15 years. While such facilities are generally safe, they often experience break-ins leaving personal possessions and commercially stored items at risk.…

Continue Reading

Friday Jul 08, 2022 - 10:41 am

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Moves One Step Closer to In-Human Trials with Completion of Preclinical Toxicity Study

Aditxt Inc. (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system, has successfully completed a toxicology study evaluating Adimune(TM), its proprietary therapeutic program. The study indicates the safety profile of ADI(TM)-100, ADTX’s immunotherapeutic technology drug, which is designed to treat the rejection of transplanted organs, skin allografting, autoimmune diseases and allergies. Calling the study results “promising,” the…

Continue Reading

Thursday Jul 07, 2022 - 1:36 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) on Track to Become Leader in Lidar

Cepton (NASDAQ: CPTN) is a developer of lidar sensors for advanced driver assistance systems (“ADAS”) and autonomous driving. “The Silicon Valley-based company made D-sample shipments in Q1 in support of GM’s Ultra Cruise program, which is the final stage before scale production, and is on track to potentially be the world’s first lidar company to have its products found in consumer vehicles,” a recent article…

Continue Reading

Thursday Jul 07, 2022 - 11:05 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Global Expansion of DehydraTECH Licensee

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its DehydraTECH licensee Boldt Runners Corporation, owners of the Cannadips brand, has expanded manufacturing agreements to include Europe, Japan and South Africa. “We are delighted with the expansion of the Cannadips brand outside of the USA,” said Chris Bunka, CEO of Lexaria Bioscience Corp. “We continue to work with the…

Continue Reading

Wednesday Jul 06, 2022 - 9:50 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Results of Annual Meeting of Shareholders, Board Appointment of Brandon Konigsberg

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that the company’s shareholders voted in favor of all of the proposals submitted for their approval at Flora’s July 5 annual meeting. In addition to the re-election of the company’s six incumbent directors, shareholders also elected Brandon Konigsberg to serve on the board. Further to his responsibilities…

Continue Reading

Tuesday Jul 05, 2022 - 11:13 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Eliminates $17.5M in Debt, in Best Financial Health in Company History

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has eliminated $17.5 million in company debt, resulting in a reduction of debt from more than $30 million last year to an estimated $11 million currently. The eliminated debt was related to a secured convertible promissory note with DBI Lease Buyback Servicing LLC, an affiliate of Drawbridge Investments LLC. The announcement noted that the company is…

Continue Reading

Friday Jul 01, 2022 - 1:14 pm

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Leveraging AI-Powered Systems to Maximize Value for B2B Base

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, leverages the power of artificial intelligence (“AI”) to maximize profits for its growing business-to-business (“B2B”) customer base. “The company offers highly modular, configurable, turnkey, and white-label gaming platforms that are compatible with all major browsers, operating systems and devices. With a focus on maximizing value for partner companies, GMGI…

Continue Reading

Friday Jul 01, 2022 - 1:03 pm

InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) AditxtScore(TM) Helping Individuals Make More Informed Decisions

Aditxt (NASDAQ: ADTX) recently partnered with Premier Medical Laboratory Services to provide individuals with personalized information regarding their immune system via the AditxtScore(TM). A recent article reads: “The AditxtScore can be used to provide those tested with important answers to questions like: Are antibodies present? How are these antibodies present – vaccine or natural immune system response? Will this immunity status provide protection from the…

Continue Reading

Thursday Jun 30, 2022 - 11:58 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Expects to Report >$61M in Cash, Cash Equivalents After Significantly Strengthening Balance Sheet

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it expects to report in excess of $61 million in cash and cash equivalents on June 30, 2022, after having significantly strengthened its balance sheet over the quarter-ending June 30, 2022. In the update, Mullen restated previously released highlights, including recent delivery of its first EV van under a pilot program to…

Continue Reading

Wednesday Jun 29, 2022 - 2:46 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Focused on International Strategy to Reach ‘Larger Consumer Base’

Flora Growth Corp. (NASDAQ: FLGC) CEO Luis Merchan is quoted in a recent article saying, “International growth is a key objective of our company’s strategy.” Earlier this year, the company completed the acquisition of 100% equity interests of Just Brands LLC and High Roller Private Label LLC, owners of the JustCBD brand, in a move by Flora Growth to explore global expansion opportunities and increase…

Continue Reading

Wednesday Jun 29, 2022 - 2:22 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) to Stand Distinct, Push Brand

Lexaria Bioscience Corp. (NASDAQ: LEXX) acknowledges consumers’ shift away from smoking cigarettes to nicotine alternatives, which has resulted in the growth of the nicotine pouch and nicotine replacement therapy (“NRT”) markets. Through its patented DehydraTECH technology, Lexaria looks to tap into the multibillion-dollar nicotine alternatives industry and stamp its position. “In a move that sought to prove DehydraTECH’s superiority, Lexaria conducted an oral nicotine absorption…

Continue Reading

Tuesday Jun 28, 2022 - 3:00 pm

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Pursuing Strategy Against COVID-19, Immune System-Related Maladies

Aditxt (NASDAQ: ADTX) is focused on developing and commercializing technologies to monitor and reprogram the immune system with the ultimate goal of improving patient outcomes for a variety of conditions. “Aditxt is joining the fight against the pandemic while pursuing a larger strategy against immune system-related maladies ranging from seasonal allergies to organ transplant rejection,” a recent article reads. “Aditxt’s first commercial product is an…

Continue Reading

Tuesday Jun 28, 2022 - 10:49 am

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Adelia Announce Achievement of Milestone

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, a biotechnology company focused on progressing Psychedelics to Therapeutics(TM), and its wholly controlled subsidiary Adelia Therapeutics Inc., have announced the achievement of a key milestone. The milestone is identified as Y2, Q3 in the contribution agreement created between Adelia and Cybin when the company acquired Adelia. Reaching the milestone means that an…

Continue Reading

Monday Jun 27, 2022 - 12:09 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Expands Collaboration Efforts with Tier 1 Supplier of Automotive Lighting Equipment

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, and Koito Manufacturing Co. Ltd (TSE: 7276), a leading automotive lighting equipment tier-1 supplier, jointly announced their intention to expand existing collaboration efforts to include select future Cepton lidar products and go-to-market activities. According to the update, detailed commercial terms are under discussion. “In the past five years, our team has…

Continue Reading

Monday Jun 27, 2022 - 11:11 am

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Moving Forward with Phase 1/2a Clinical Trial after Receiving Key FDA Approval

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has received approval from the U.S. Food and Drug Administration (“FDA”) to proceed with its phase 1/2a first-in-human clinical trial evaluating CYB003; the company has received a “may proceed” letter and investigational new drug application (“IND”) clearance from the FDA. The approval means that CYB003 will be the first  novel psilocybin analog…

Continue Reading

Thursday Jun 23, 2022 - 1:37 pm

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Shareholder Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today provided an update to its shareholders, including recent highlights and accomplishments for the company, the Mullen FIVE and the Mullen EV Van programs. Among the various highlights, the company reported that its solid-state polymer battery cell was successfully tested for the second time at Battery Innovation Center (“BIC”) in Indiana. The follow-up testing through…

Continue Reading

Wednesday Jun 22, 2022 - 11:49 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Files 130+ US, International Patent Applications for Mullen FIVE EV Crossover

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has filed over 130 patents in 24 countries in support of the Mullen FIVE EV Crossover program. Per the update, the 130-plus patent applications relate to Mullen FIVE EV’s design and styling of its exterior and interior. They include areas such as vehicle bodywork, headlights and taillights, doors, mirrors, rims, headliners,…

Continue Reading

Wednesday Jun 22, 2022 - 11:42 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Business Highlights, FY 2022 Results

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today reported recent business highlights and audited financial results for its fiscal year ended March 31, 2022. In addition, the company reiterated its anticipated pipeline and strategic milestones for the remainder of 2022. “Cybin made important progress across the board in recent months, accelerating both our pipeline of proprietary investigational…

Continue Reading

Tuesday Jun 21, 2022 - 3:01 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Enters Strategic Manufacturing, License Agreements with BevNology

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the signing of two agreements with Atlanta-based BevNology LLC. According to the update, the first manufacturing operating agreement expands production capabilities for Lexaria’s own growing list of business-to-business (“B2B”) clientele interested in purchasing DehydraTECH-powered active ingredients for consumer packaged-goods brands. A new, state-of-the-art processing facility custom-built by BevNology is operational that…

Continue Reading

Tuesday Jun 21, 2022 - 2:20 pm

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Extension of Senior Secured Convertible Note

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has extended the maturity of a senior secured convertible note of $28 million, originally due in July 2022, by two years. According to the update, the company originally entered into a secured convertible promissory note on July 23, 2020, with DBI Lease Buyback Servicing LLC, an affiliate of Drawbridge Investments LLC.…

Continue Reading

Tuesday Jun 21, 2022 - 1:25 pm

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Featured in Latest Episode of Bell2Bell Podcast

Golden Matrix Group (NASDAQ: GMGI), a gaming technology company, was featured in the Bell2Bell Podcast, a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. GMGI’s CEO Brian Goodman joined the latest episode to discuss Golden Matrix’s business model, which includes both business-to-business (“B2B”) and business-to-consumer (“B2C”) operations. “Our core business is B2B. We build gaming systems and provide…

Continue Reading

Tuesday Jun 21, 2022 - 11:44 am

InvestorNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Speaker Lineup for Sequire Decentralized Web Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has announced a slate of influential industry experts that will be speakers at the Sequire Decentralized Web Conference. The event, to take place from 10:00 am ET to 6:00 pm ET on Thursday, June 23, 2022, is bringing together a list of influential…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).